Large inter-individual variability exists regarding how our gut microbiota responds to dietary intervention. New findings in mice and people with obesity show that ‘responders’ to inulin may be identifiable from their gut microbiota before they receive the intervention.
Gut microbiota composition tied to type 2 diabetes remission following bariatric surgery in obese diabetic women
9 Mar 2020by Andreu Prados
Our gut microbiota profile may help us understand the contribution of bariatric surgery to weight loss. New findings reveal gut microbiota composition before Roux-en-Y gastric bypass is associated with type 2 diabetes remission in obese diabetic women.
A new review explores how the gastrointestinal sensing of meal-related stimuli occur in health and disease
10 Feb 2020by GMFH Editing Team
A large proportion of the general population struggle with digestive symptoms that cannot be detected by conventional diagnostic methods. Understanding how the gastrointestinal tract responds to meal-related stimuli may help both in healthy conditions and in eating-related disorders.
2019 at a glance: Breakthroughs in the emerging role of gut microbiome in health and disease
13 Jan 2020by GMFH Editing Team
Important scientific progress has been made in 2019 in our understanding of the contribution of gut microbiome in health and disease. Have a look at this “2019 Year at a glance” report and discover the year’s breakthroughs in the field.
New GMFH “best of” document presents current progress and health applications of synbiotics
28 Nov 2019by GMFH Editing Team
Gibson and Roberfroid were the first to anticipate that probiotics and prebiotics could be combined as synbiotics back in 1995. Mary Ellen Sanders and Andreu Prados introduce our new selection of human research on the health benefits of synbiotics.
Excess levels of ethanol-producing Klebsiella pneumoniae strain emerge as new potential culprit for fatty liver disease
11 Nov 2019by GMFH Editing Team
Could people become drunk without touching any booze? A K. pneumoniae strain with the ability to produce alcohol endogenously has been identified as a novel culprit that may accelerate the development of non-alcoholic fatty liver disease.
Scientists identify gut microbiome taxonomic and functional profiles that uniquely characterize obesity and type 2 diabetes
7 Nov 2019by GMFH Editing Team
Ruling out the specific contribution of obesity and type 2 diabetes in gut microbiome variation is a challenge. Louise Thingholm and colleagues have found that while obesity is linked to gut microbiome variation, gut microbiome associations with type 2 diabetes are modest.
A Bifidobacterium probiotic strain may reduce aspirin-related intestinal damage in healthy volunteers
4 Nov 2019by Andreu Prados
Small intestinal damage is a known side effect of nonsteroidal anti-inflammatory drugs. A new double-blind, placebo-controlled study has found that the probiotic Bifidobacterium breve Bif195 may alleviate Aspirin-induced ulcers in healthy adults.
Conventional yogurt may have protective effects in patients with insulin resistance
23 Sep 2019by GMFH Editing Team
Gut health has emerged as a potential target in people suffering from metabolic syndrome. A new randomized controlled trial has found that yogurt may help ameliorate insulin resistance in obese women with nonalcoholic fatty liver disease and metabolic syndrome by involving the gut microbiota.
Human milk oligosaccharides are detectable in serum and may affect maternal metabolism
19 Sep 2019by GMFH Editing Team
Human milk oligosaccharides (HMOs) benefits don’t seem to be limited to the gut microbiota. Indeed, HMOs are present in maternal serum and may have systemic metabolic implications for both maternal and fetal health during pregnancy.